trc120038, a novel dual at1eta receptor blocker for control of hypertension, diabetic nephropathy, and cardiomyopathy in ob-zsf1 ratstrc120038,一种新颖的双at1eta受体阻滞剂控制高血压、糖尿病肾病、心肌病ob-zsf1老鼠.pdfVIP

  • 7
  • 0
  • 约8.82万字
  • 约 13页
  • 2017-08-29 发布于上海
  • 举报

trc120038, a novel dual at1eta receptor blocker for control of hypertension, diabetic nephropathy, and cardiomyopathy in ob-zsf1 ratstrc120038,一种新颖的双at1eta受体阻滞剂控制高血压、糖尿病肾病、心肌病ob-zsf1老鼠.pdf

trc120038, a novel dual at1eta receptor blocker for control of hypertension, diabetic nephropathy, and cardiomyopathy in ob-zsf1 ratstrc120038,一种新颖的双at1eta受体阻滞剂控制高血压、糖尿病肾病、心肌病ob-zsf1老鼠

SAGE-Hindawi Access to Research International Journal of Hypertension Volume 2011, Article ID 751513, 12 pages doi:10.4061/2011/751513 Research Article TRC120038, a Novel Dual AT1/ETA Receptor Blocker for Control of Hypertension, Diabetic Nephropathy, and Cardiomyopathy in ob-ZSF1 Rats Anookh Mohanan, Ram Gupta, Amita Dubey, Vikrant Jagtap, Appaji Mandhare, Ramesh C. Gupta, Vijay Chauthaiwale, and Chaitanya Dutt Torrent Research Centre, Torrent Pharmaceuticals Ltd., Gujarat, Gandhinagar 382428, India Correspondence should be addressed to

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档